Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

FK506 may stimulate hair growth when applied to the skin.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Latanoprost can make eyelashes longer, thicker, and darker.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

No treatment fully prevents hair loss from chemotherapy yet.

Dexamethasone speeds up hair loss in mice, while cyclosporin A slows it down.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.